Caitong International Asset Management’s Soleno Therapeutics SLNO Stock Holding History

Caitong International Asset Management’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-8,586	Closed	-$287K	–	3412
2026 Q1	$287K	Buy	8,586 +7,764	+945%	+$304K	0.05%	300
2025 Q4	$38.1K	Buy	+822	New	+$45.1K	0.01%	807
2025 Q3	–	Sell	-19	Closed	-$1.59K	–	2460
2025 Q2	$1.59K	Sell	19 -250	-93%	-$18.7K	﹤0.01%	1449
2025 Q1	$19.2K	Sell	269 -502	-65%	-$24.4K	0.01%	752
2024 Q4	$34.7K	Buy	+771	New	+$39.9K	0.03%	609

Caitong International Asset Management's SLNO Position: Q2 2026 in Review

Caitong International Asset Management sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 8,586 shares — an estimated $287K sold.

Caitong International Asset Management first reported a position in SLNO in Q4 2024 and held it in 5 quarters. The position peaked at $287K in Q1 2026. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Caitong International Asset Management reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Caitong International Asset Management sold 8,586 Soleno Therapeutics shares in Q2 2026, an estimated $287K.
Caitong International Asset Management first reported a position in Soleno Therapeutics in Q4 2024 and held it in 5 quarters.
Caitong International Asset Management's Soleno Therapeutics position peaked at $287K in Q1 2026.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.